Federal Project Grant Award Summary

The National Institute of Allergy and Infectious Diseases (NIAID) awarded $805,866 to the University of Georgia Research Foundation, Inc. on May 12, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop and validate advanced predictive models for influenza vaccine responses. The project, which extends through April 30, 2031, will deliver statistical and machine-learning models that incorporate longitudinal antibody response data and heterologous strain information to improve predictions of vaccine effectiveness across diverse populations. The research addresses critical limitations in existing predictive approaches by integrating dynamic immune system data beyond pre-vaccination baseline measurements and accounting for non-vaccine-specific antibody responses, thereby enabling more accurate and adaptable vaccine efficacy predictions across multiple influenza viral strains.

The deliverables under this award include predictive models that forecast both vaccine-strain-specific responses and heterologous breadth of antibody reactions, with the ultimate goal of supporting tailored vaccination strategies. This research directly advances the program's objective to support investigator-initiated biomedical research that improves understanding of infectious disease mechanisms and enhances vaccine development approaches, contributing to public health outcomes through enhanced personalization of influenza vaccination strategies and improved protection efficacy prediction.